Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics (NASDAQ:CARA) Cut to "Hold" at Zacks Investment Research
06:20am, Saturday, 18'th Apr 2020
Zacks Investment Research downgraded shares of Cara Therapeutics (NASDAQ:CARA) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “Cara The
Zacks Investment Research Upgrades Cara Therapeutics (NASDAQ:CARA) to Buy
10:52am, Thursday, 16'th Apr 2020
Cara Therapeutics (NASDAQ:CARA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm presently has a $1
Baldwin Brothers Inc. MA Sells 5,327 Shares of Cara Therapeutics Inc (NASDAQ:CARA)
09:21am, Thursday, 16'th Apr 2020
Baldwin Brothers Inc. MA reduced its stake in Cara Therapeutics Inc (NASDAQ:CARA) by 23.8% during the first quarter, HoldingsChannel.com reports. The firm owned 17,027 shares of the biopharmaceutical
Cara Therapeutics (CARA) Gets a Buy Rating from Needham
06:52pm, Wednesday, 15'th Apr 2020
Needham analyst Alan Carr maintained a Buy rating on Cara Therapeutics (CARA) today and set a price target of $35.00. The company's shares closed last
Cara Therapeutics (CARA) Gets a Buy Rating from Needham
06:52pm, Wednesday, 15'th Apr 2020
Needham analyst Alan Carr maintained a Buy rating on Cara Therapeutics (CARA – Research Report) today and set a price
UBS Asset Management Americas Inc. Has $544,000 Stake in Cara Therapeutics Inc (NASDAQ:CARA)
10:22am, Monday, 13'th Apr 2020
UBS Asset Management Americas Inc. raised its stake in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 5.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned
Ladenburg Thalmann Financial Services Inc. Sells 12,187 Shares of Cara Therapeutics Inc (NASDAQ:CARA)
09:30am, Monday, 13'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lessened its position in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 30.7% during the 4th quarter, according to its most recent Form 13F filing with the
Cannabis Central: Universe Of 299 Pot Stocks Operate In These 11 Categories
09:16am, Monday, 13'th Apr 2020
299 cannabis companies have securities that actively trade on the various stock exchanges in Canada & the U.S.within 11 categories based on their primary area of focus.
AQR Capital Management LLC Decreases Stock Holdings in Cara Therapeutics Inc (NASDAQ:CARA)
08:50am, Monday, 13'th Apr 2020
AQR Capital Management LLC lowered its stake in Cara Therapeutics Inc (NASDAQ:CARA) by 5.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchang
Cara Therapeutics Inc (NASDAQ:CARA) Given Average Rating of "Buy" by Brokerages
07:34am, Monday, 13'th Apr 2020
Shares of Cara Therapeutics Inc (NASDAQ:CARA) have been assigned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the stock, Marketbeat.com reports. One re
Cara Therapeutics (NASDAQ:CARA) Lowered to "Hold" at Zacks Investment Research
10:18am, Sunday, 12'th Apr 2020
Zacks Investment Research downgraded shares of Cara Therapeutics (NASDAQ:CARA) from a buy rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Cara Therap
Have Insiders Been Selling Cara Therapeutics, Inc. (NASDAQ:CARA) Shares This Year?
12:42pm, Saturday, 11'th Apr 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Goldman Sachs Group Inc. Sells 48,153 Shares of Cara Therapeutics Inc (NASDAQ:CARA)
10:16am, Saturday, 11'th Apr 2020
Goldman Sachs Group Inc. decreased its position in Cara Therapeutics Inc (NASDAQ:CARA) by 16.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor own
Bank of America Corp DE Acquires 241,271 Shares of Cara Therapeutics Inc (NASDAQ:CARA)
08:42am, Friday, 10'th Apr 2020
Bank of America Corp DE lifted its holdings in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 133.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 421,581 shares of the biopha
Franklin Resources Inc. Decreases Holdings in Cara Therapeutics Inc (NASDAQ:CARA)
09:40am, Thursday, 09'th Apr 2020
Franklin Resources Inc. decreased its holdings in Cara Therapeutics Inc (NASDAQ:CARA) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission
